SUBSCRIBE
SUBSCRIBE
News   Drug Development

Anavex Life Sciences Corp. Announces Its Preclinical Pipeline Of Novel Oncology Therapies

February 12, 2007 | 
1 min read
KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- February 12, 2007 -- Anavex Life Sciences Corp. (the "Company") (OTCBB: AVXL) announces its strategic vision for growth by discovering and developing cutting-edge drugs against solid tumors.
Preclinical
Anavex Life Sciences Corp.
MORE ON THIS TOPIC
Hand holding a lung shape symbol against a blue background. World tuberculosis day, world no tobacco day, lung cancer, pulmonary hypertension, pneumonia
Lung cancer
AstraZeneca’s ATR Inhibitor Fails to Improve Survival in Phase III Lung Cancer Trial
December 22, 2025
 · 
1 min read
 · 
Annalee Armstrong
Digital overload and its impact on the human brain, showcasing fragmented thoughts, information overload. Abstract design art collage. Social media digital addiction, mental health, stress, anxiety
Business
BioSpace Editors’ Top 5 Biggest News Stories of the Year
December 22, 2025
 · 
10 min read
 · 
Annalee Armstrong
Balloon and missed bow spears arround . Target audience and marketing concept . This is a 3d render illustration .
Infectious disease
Insmed Delivers ‘Rare Disappointment’ as Brinsupri Flops in Mid-Stage Rhinosinusitis Study
December 19, 2025
 · 
2 min read
 · 
Tristan Manalac
Man holds up his hand to signify a pause or stop
ADCs
Patient Deaths Put Merck, Daiichi Sankyo’s Antibody-Drug Conjugate on Hold
December 19, 2025
 · 
2 min read
 · 
Tristan Manalac